Table 1.

Cohort 2 patient characteristics.

PatientsAge (yr)BMI (kg/m2)DiabetesPrior CFTUrine culture historyUrine culture before CFT
PNK0165832.2IDDMNoPseudomonas aeruginosa and Proteus mirabilisEnterococcus faecalis (105)
PNK0176525.3NoNoP. aeruginosa, Escherichia coli, and E. faecalisNo growth
PNK0186224.0NoNoKlebsiella pneumoniae, E. coli, and E. faecalisNo growth
PNK0198022.5NoNoE. faecalis and K. pneumoniaeNo growth
PNK0205131.9NoNoE. coliNo growth
PNK0228827.5NoNoE. coliNo growth
PNK0238220.7NoNoK. pneumoniaeK. pneumoniae (105)
PNK0245830.9AODMYesK. pneumoniaeNo growth
PNK0256641.2NoNoE. coliNo growth
PNK0266535.0AODMNoE. coliNo growth
PNK0277722.0NoYesE. coli and E. faecalisEnterococcus faecium (105), Aerococcus urinae (55–99,000)
  • Relevant patient data recorded for the 11 study participants. BMI, body mass index. Diabetes: no, nondiabetic; IDDM, diabetes mellitus type 1; AODM, adult-onset diabetes mellitus type 2; CFT, cystoscopy with fulguration of trigonitis. Urine cultures performed in clinical laboratories with a 104 CFU/ml detection limit.